Download PDF
J Knee Surg 2018; 31(01): 056-067
DOI: 10.1055/s-0037-1600092
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA

Intra-articular Tranexamic Acid in Primary Total Knee Arthroplasty: Meta-analysis

Joseph T. Moskal
1   Department of Orthopaedic Surgery, Virginia Tech Carilion School of Medicine, Roanoke, Virginia
,
Susan G. Capps
2   BENSOL, Warsaw, Indiana
› Author Affiliations
Further Information

Publication History

15 August 2016

06 February 2017

Publication Date:
10 April 2017 (online)

    Permissions and Reprints

Abstract

Total knee arthroplasty (TKA) is associated with an increased need for blood transfusions and thus an increase in risks associated with blood transfusion such as transfusion reactions, infections, fluid overload, and altered mental status. Tranexamic acid (TXA) is an antifibrinolytic medication that can reduce perioperative blood loss in TKA. However, the best method of delivery has not been defined although topical intra-articular TXA (IA-TXA) may have a theoretical advantage as it is applied directly when and where it is needed to control bleeding. Blinded and nonblinded randomized controlled trials and case-controlled trials published since 2010 were found using database searches. Data were extracted and analyzed with the goal of discovering through meta-analysis if IA-TXA reduces blood loss, blood transfusions, and without increasing adverse events, especially thromboembolic events, compared with placebo. Blood loss from suction drains and calculated total blood loss were significantly lower in the IA-TXA group. The frequency of blood transfusion and the number of units of blood transfused were significantly lower in the IA-TXA group. The risk of adverse events was not increased for IA-TXA versus placebo. Topical IA-TXA in primary, unilateral TKA successfully reduces blood loss and the frequency of blood transfusions. In addition, it does not appear to increase the risk of thromboembolic adverse events. There is need for further research to determine the optimal dosage and the preferred delivery system of IA-TXA in TKA.

Keywords

intra-articular tranexamic acid - total knee arthroplasty - blood loss - blood transfusion - adverse events
 

  • References

  • 1 Chimento GF, Huff T, Ochsner Jr JL, Meyer M, Brandner L, Babin S. An evaluation of the use of topical tranexamic acid in total knee arthroplasty. J Arthroplasty 2013; 28 (8, Suppl): 74-77
    CrossrefPubMedGoogle Scholar
  • 2 Friedman R, Homering M, Holberg G, Berkowitz SD. Allogeneic blood transfusions and postoperative infections after total hip or knee arthroplasty. J Bone Joint Surg Am 2014; 96 (04) 272-278
    CrossrefPubMedGoogle Scholar
  • 3 Gilbody J, Dhotar HS, Perruccio AV, Davey JR. Topical tranexamic acid reduces transfusion rates in total hip and knee arthroplasty. J Arthroplasty 2014; 29 (04) 681-684
    CrossrefPubMedGoogle Scholar
  • 4 Henry D, Carless P, Fergusson D, Laupacis A. The safety of aprotinin and lysine-derived antifibrinolytic drugs in cardiac surgery: a meta-analysis. CMAJ 2009; 180 (02) 183-193
    CrossrefPubMedGoogle Scholar
  • 5 Wind TC, Barfield WR, Moskal JT. The effect of tranexamic acid on blood loss and transfusion rate in primary total knee arthroplasty. J Arthroplasty 2013; 28 (07) 1080-1083
    CrossrefPubMedGoogle Scholar
  • 6 Alshryda S, Sarda P, Sukeik M, Nargol A, Blenkinsopp J, Mason JM. Tranexamic acid in total knee replacement: a systematic review and meta-analysis. J Bone Joint Surg Br 2011; 93 (12) 1577-1585
    CrossrefPubMedGoogle Scholar
  • 7 Alshryda S, Sukeik M, Sarda P, Blenkinsopp J, Haddad FS, Mason JM. A systematic review and meta-analysis of the topical administration of tranexamic acid in total hip and knee replacement. Bone Joint J 2014; 96-B (08) 1005-1015
    CrossrefPubMedGoogle Scholar
  • 8 Cid J, Lozano M. Tranexamic acid reduces allogeneic red cell transfusions in patients undergoing total knee arthroplasty: results of a meta-analysis of randomized controlled trials. Transfusion 2005; 45 (08) 1302-1307
    CrossrefPubMedGoogle Scholar
  • 9 Fu DJ, Chen C, Guo L, Yang L. Use of intravenous tranexamic acid in total knee arthroplasty: a meta-analysis of randomized controlled trials. Chin J Traumatol 2013; 16 (02) 67-76
    PubMedGoogle Scholar
  • 10 Gandhi R, Evans HM, Mahomed SR, Mahomed NN. Tranexamic acid and the reduction of blood loss in total knee and hip arthroplasty: a meta-analysis. BMC Res Notes 2013; 6: 184
    CrossrefPubMedGoogle Scholar
  • 11 Ho KM, Ismail H. Use of intravenous tranexamic acid to reduce allogeneic blood transfusion in total hip and knee arthroplasty: a meta-analysis. Anaesth Intensive Care 2003; 31 (05) 529-537
    PubMedGoogle Scholar
  • 12 Panteli M, Papakostidis C, Dahabreh Z, Giannoudis PV. Topical tranexamic acid in total knee replacement: a systematic review and meta-analysis. Knee 2013; 20 (05) 300-309
    CrossrefPubMedGoogle Scholar
  • 13 Shemshaki H, Nourian SM, Nourian N, Dehghani M, Mokhtari M, Mazoochian F. One step closer to sparing total blood loss and transfusion rate in total knee arthroplasty: a meta-analysis of different methods of tranexamic acid administration. Arch Orthop Trauma Surg 2015; 135 (04) 573-588
    CrossrefPubMedGoogle Scholar
  • 14 Tan J, Chen H, Liu Q, Chen C, Huang W. A meta-analysis of the effectiveness and safety of using tranexamic acid in primary unilateral total knee arthroplasty. J Surg Res 2013; 184 (02) 880-887
    CrossrefPubMedGoogle Scholar
  • 15 Wang H, Shen B, Zeng Y. Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials. Knee 2014; 21 (06) 987-993
    CrossrefPubMedGoogle Scholar
  • 16 Wei Z, Liu M. The effectiveness and safety of tranexamic acid in total hip or knee arthroplasty: a meta-analysis of 2720 cases. Transfus Med 2015; 25 (03) 151-162
    CrossrefPubMedGoogle Scholar
  • 17 Wu Q, Zhang HA, Liu SL, Meng T, Zhou X, Wang P. Is tranexamic acid clinically effective and safe to prevent blood loss in total knee arthroplasty? A meta-analysis of 34 randomized controlled trials. Eur J Orthop Surg Traumatol 2015; 25 (03) 525-541
    CrossrefPubMedGoogle Scholar
  • 18 Yang ZG, Chen WP, Wu LD. Effectiveness and safety of tranexamic acid in reducing blood loss in total knee arthroplasty: a meta-analysis. J Bone Joint Surg Am 2012; 94 (13) 1153-1159
    CrossrefPubMedGoogle Scholar
  • 19 Zhang H, Chen J, Chen F, Que W. The effect of tranexamic acid on blood loss and use of blood products in total knee arthroplasty: a meta-analysis. Knee Surg Sports Traumatol Arthrosc 2012; 20 (09) 1742-1752
    CrossrefPubMedGoogle Scholar
  • 20 Zhang Y, Fu X, Liu WX, Li YM, Ma XL, Li ZJ. Safety and efficacy of intra-articular injection of tranexamic acid in total knee arthroplasty. Orthopedics 2014; 37 (09) e775-e782
    CrossrefPubMedGoogle Scholar
  • 21 Zhao-Yu C, Yan G, Wei C, Yuejv L, Ying-Ze Z. Reduced blood loss after intra-articular tranexamic acid injection during total knee arthroplasty: a meta-analysis of the literature. Knee Surg Sports Traumatol Arthrosc 2014; 22 (12) 3181-3190
    CrossrefPubMedGoogle Scholar
  • 22 Liberati A, Altman DG, Tetzlaff J. , et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 2009; 6 (07) e1000100
    CrossrefPubMedGoogle Scholar
  • 23 Chen JY, Rikhraj IS, Zhou Z. , et al. Can tranexamic acid and hydrogen peroxide reduce blood loss in cemented total knee arthroplasty?. Arch Orthop Trauma Surg 2014; 134 (07) 997-1002
    CrossrefPubMedGoogle Scholar
  • 24 Konig G, Hamlin BR, Waters JH. Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty. J Arthroplasty 2013; 28 (09) 1473-1476
    CrossrefPubMedGoogle Scholar
  • 25 Gillette BP, Maradit Kremers H, Duncan CM. , et al. Economic impact of tranexamic acid in healthy patients undergoing primary total hip and knee arthroplasty. J Arthroplasty 2013; 28 (8, Suppl): 137-139
    CrossrefPubMedGoogle Scholar
  • 26 Gomez-Barrena E, Ortega-Andreu M, Padilla-Eguiluz NG, Pérez-Chrzanowska H, Figueredo-Zalve R. Topical intra-articular compared with intravenous tranexamic acid to reduce blood loss in primary total knee replacement: a double-blind, randomized, controlled, noninferiority clinical trial. J Bone Joint Surg Am 2014; 96 (23) 1937-1944
    CrossrefPubMedGoogle Scholar
  • 27 Hamlin BR, DiGioia AM, Plakseychuk AY, Levison TJ. Topical versus intravenous tranexamic acid in total knee arthroplasty. J Arthroplasty 2015; 30 (03) 384-386
    CrossrefPubMedGoogle Scholar
  • 28 Moskal JT, Harris RN, Capps SG. Transfusion cost savings with tranexamic acid in primary total knee arthroplasty from 2009 to 2012. J Arthroplasty 2015; 30 (03) 365-368
    CrossrefPubMedGoogle Scholar
  • 29 Patel JN, Spanyer JM, Smith LS, Huang J, Yakkanti MR, Malkani AL. Comparison of intravenous versus topical tranexamic acid in total knee arthroplasty: a prospective randomized study. J Arthroplasty 2014; 29 (08) 1528-1531
    CrossrefPubMedGoogle Scholar
  • 30 Slover J, Bosco J. Cost analysis of use of tranexamic acid to prevent major bleeding complications in hip and knee arthroplasty surgery. Am J Orthop 2014; 43 (10) E217-E220
    PubMedGoogle Scholar
  • 31 Soni A, Saini R, Gulati A, Paul R, Bhatty S, Rajoli SR. Comparison between intravenous and intra-articular regimens of tranexamic acid in reducing blood loss during total knee arthroplasty. J Arthroplasty 2014; 29 (08) 1525-1527
    CrossrefPubMedGoogle Scholar
  • 32 Alshryda S, Mason J, Vaghela M. , et al. Topical (intra-articular) tranexamic acid reduces blood loss and transfusion rates following total knee replacement: a randomized controlled trial (TRANX-K). J Bone Joint Surg Am 2013; 95 (21) 1961-1968
    CrossrefPubMedGoogle Scholar
  • 33 Craik JD, Ei Shafie SA, Kidd AG, Twyman RS. Can local administration of tranexamic acid during total knee arthroplasty reduce blood loss and transfusion requirements in the absence of surgical drains?. Eur J Orthop Surg Traumatol 2014; 24 (03) 379-384
    CrossrefPubMedGoogle Scholar
  • 34 Georgiadis AG, Muh SJ, Silverton CD, Weir RM, Laker MW. A prospective double-blind placebo controlled trial of topical tranexamic acid in total knee arthroplasty. J Arthroplasty 2013; 28 (8, Suppl): 78-82
    CrossrefPubMedGoogle Scholar
  • 35 Jang B, Kao M, Bohm MT, Harris IA, Chen DB, MacDessi SJ. Intra-articular injection of tranexamic acid to reduce blood loss after total knee arthroplasty. J Orthop Surg (Hong Kong) 2014; 22 (02) 146-149
    CrossrefPubMedGoogle Scholar
  • 36 Maniar RN, Kumar G, Singhi T, Nayak RM, Maniar PR. Most effective regimen of tranexamic acid in knee arthroplasty: a prospective randomized controlled study in 240 patients. Clin Orthop Relat Res 2012; 470 (09) 2605-2612
    CrossrefPubMedGoogle Scholar
  • 37 Mutsuzaki H, Ikeda K. Intra-articular injection of tranexamic acid via a drain plus drain-clamping to reduce blood loss in cementless total knee arthroplasty. J Orthop Surg 2012; 7: 32
    CrossrefPubMedGoogle Scholar
  • 38 Roy SP, Tanki UF, Dutta A, Jain SK, Nagi ON. Efficacy of intra-articular tranexamic acid in blood loss reduction following primary unilateral total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc 2012; 20 (12) 2494-2501
    CrossrefPubMedGoogle Scholar
  • 39 Sa-Ngasoongsong P, Channoom T, Kawinwonggowit V. , et al. Postoperative blood loss reduction in computer-assisted surgery total knee replacement by low dose intra-articular tranexamic acid injection together with 2-hour clamp drain: a prospective triple-blinded randomized controlled trial. Orthop Rev (Pavia) 2011; 3 (02) e12
    CrossrefPubMedGoogle Scholar
  • 40 Sa-Ngasoongsong P, Wongsak S, Chanplakorn P. , et al. Efficacy of low-dose intra-articular tranexamic acid in total knee replacement; a prospective triple-blinded randomized controlled trial. BMC Musculoskelet Disord 2013; 14: 340
    CrossrefPubMedGoogle Scholar
  • 41 Seo JG, Moon YW, Park SH, Kim SM, Ko KR. The comparative efficacies of intra-articular and IV tranexamic acid for reducing blood loss during total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc 2013; 21 (08) 1869-1874
    CrossrefPubMedGoogle Scholar
  • 42 Wong J, Abrishami A, El Beheiry H. , et al. Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial. J Bone Joint Surg Am 2010; 92 (15) 2503-2513
    CrossrefPubMedGoogle Scholar
  • 43 Yang Y, Lv YM, Ding PJ, Li J, Ying-Ze Z. The reduction in blood loss with intra-articular injection of tranexamic acid in unilateral total knee arthroplasty without operative drains: a randomized controlled trial. Eur J Orthop Surg Traumatol 2015; 25 (01) 135-139
    PubMedGoogle Scholar
  • 44 Centre for evidence-based medicine. Levels of evidence. Available at: http://www.cebm.net/index.aspx?o=1025 Accessed July 8, 2011
    PubMed
  • 45 Jadad AR, Moore RA, Carroll D. , et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials 1996; 17 (01) 1-12
    CrossrefPubMedGoogle Scholar
  • 46 Oremus M, Wolfson C, Perrault A, Demers L, Momoli F, Moride Y. Interrater reliability of the modified Jadad quality scale for systematic reviews of Alzheimer's disease drug trials. Dement Geriatr Cogn Disord 2001; 12 (03) 232-236
    CrossrefPubMedGoogle Scholar
  • 47 Sassoon A, Nam D, Nunley R, Barrack R. Systematic review of patient-specific instrumentation in total knee arthroplasty: new but not improved. Clin Orthop Relat Res 2015; 473 (01) 151-158
    CrossrefPubMedGoogle Scholar
  • 48 Wells G, Shea B, O'Connell D. , et al. Available at: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp Accessed May 1, 2016
    PubMed
  • 49 Borenstein M, Hedges LV, Higgins JP, Rothstein HR. Fixed-effect versus random-effects models. In: Introduction to Meta-Analysis. West Sussex, UK: John Wiley & Sons Ltd; 2009: 77
    Google Scholar
  • 50 Friedrich JO, Adhikari NK, Beyene J. Inclusion of zero total event trials in meta-analyses maintains analytic consistency and incorporates all available data. BMC Med Res Methodol 2007; 7: 5
    CrossrefPubMedGoogle Scholar